Ebrahim Haroon, MD

Trials

Studies that name Ebrahim Haroon, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:03 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06580145 · Leucine in Midlife Depression

  Emory University · recruiting · Major Depression · principal investigator
• Ph4
  NCT03004443 · Inflammation-Induced CNS Glutamate Changes in Depression

  Emory University · terminated · Depression · principal investigator
• N/A
  NCT02567110 · Magnetic Resonance Spectroscopy (MRS) in Midlife Depression

  Emory University · completed · Depression, Depression Bipolar · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leucine as a Probe of Kynurenine-Induced Glutamate and Neural Circuit Dysfunction in Midlife Depression
  R01MH132059 · NIMH · EMORY UNIVERSITY · PI Ebrahim Haroon · fiscal years 2023 to 2026
  Named on NCT06580145
• Inflammation-Induced CNS Glutamate Changes in Depression
  R01MH112076 · NIMH · EMORY UNIVERSITY · PI Ebrahim Haroon, ANDREW H MILLER · fiscal years 2016 to 2020
  Named on NCT03004443
• Inflammation-Induced CNS Glutamate as a Function of Depression in Middle Age
  R01MH107033 · NIMH · EMORY UNIVERSITY · PI Ebrahim Haroon · fiscal years 2016 to 2021
  Named on NCT02567110